Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555957 · ClinicalTrials.gov registry record · Phase 3
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
A Phase 3 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
NCT01555957 is a Phase 3 study that has completed, run by University of Rochester. The registered enrollment target is 40 participants.
The verdict
NCT01555957, a Phase 3 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
Study Summary
The Investigators hypothesize that increased cumulative amount of lipid intake causes PNAC in late preterm and term neonates with major GI surgical disorders
Interventions
- DRUG intravenous lipid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-02 |
| Est. Completion | 2019-01-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555957
The ClinicalTrials.gov registry entry for NCT01555957 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intravenous lipid is the first listed.
NCT01555957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01555957 about?
NCT01555957 is a clinical study titled "Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis". The Investigators hypothesize that increased cumulative amount of lipid intake causes PNAC in late preterm and term neonates with major GI surgical disorders
What is the current status of trial NCT01555957?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2012-02. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT01555957?
The interventions under investigation include: intravenous lipid (DRUG).
Who is sponsoring clinical trial NCT01555957?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.